Data / Form D filings / Elucid Bioimaging Inc.
Elucid Bioimaging Inc.: Form D filings
Elucid Bioimaging Inc., a biotechnology company in Boston, MA, filed 4 Form D notices with the SEC between 2013 and 2026. The latest, on October 27, 2026, reports $56.2 million sold of a $80 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 PARK PLAZA SUITE 700, Boston, MA, 02116
- Phone
- (617) 329-9487
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1585931
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Amendment | $79,999,999 | $56,235,000 | $23,764,999 | 20 | Oct 10, 2025 | sec.gov |
| Oct 22, 2025 | New notice | $79,999,999 | $36,495,008 | $43,504,991 | 9 | Oct 10, 2025 | sec.gov |
| Nov 22, 2023 | New notice | $78,950,836 | $78,950,836 | 13 | Oct 20, 2023 | sec.gov | |
| Sep 10, 2013 | New notice | $1,500,000 | $375,000 | $1,125,000 | 1 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Blake Richards | Executive Officer | |
| Scott Huennekens | Director | |
| Michael Lesh | Director | |
| Richard Kuntz | Director | |
| Evan Melrose | Director | |
| Shamiram Feinglass | Director | |
| Kelly Huang | Executive Officer, Director | |
| Rajesh Panda | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
Every Form D from the week of Oct 26, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Elucid Bioimaging Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.